These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31385929)

  • 21. The Role of HLA Antibodies in HLA Mismatched Allogeneic Hematopoietic Stem Cell Transplantation.
    Zhang X; Wang J; Zhou Z; Zhang Y; Liu H; Tong C; Yu C; Lu Y; Zhao Y; Xiong M; Zhou JR; Juan S; Liu DY; Wei Z; Zhang J; Wu T; Lu DP
    Clin Transpl; 2014; ():245-50. PubMed ID: 26281152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.
    Tait BD; Süsal C; Gebel HM; Nickerson PW; Zachary AA; Claas FH; Reed EF; Bray RA; Campbell P; Chapman JR; Coates PT; Colvin RB; Cozzi E; Doxiadis II; Fuggle SV; Gill J; Glotz D; Lachmann N; Mohanakumar T; Suciu-Foca N; Sumitran-Holgersson S; Tanabe K; Taylor CJ; Tyan DB; Webster A; Zeevi A; Opelz G
    Transplantation; 2013 Jan; 95(1):19-47. PubMed ID: 23238534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antihuman leukocyte antigen–specific antibody strength determined by complement-dependent or solid-phase assays can predict positive donor-specific crossmatches.
    Batal I; Zeevi A; Lunz JG; Aggarwal N; Shapiro R; Randhawa P; Girnita A
    Arch Pathol Lab Med; 2010 Oct; 134(10):1534-40. PubMed ID: 20923311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Virtual Crossmatch: An Essential Tool for Transplanting Sensitized Patients.
    Jackson AM
    Clin Transpl; 2014; ():131-6. PubMed ID: 26281137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kidney Transplant With Low Levels of DSA or Low Positive B-Flow Crossmatch: An Underappreciated Option for Highly Sensitized Transplant Candidates.
    Schinstock CA; Gandhi M; Cheungpasitporn W; Mitema D; Prieto M; Dean P; Cornell L; Cosio F; Stegall M
    Transplantation; 2017 Oct; 101(10):2429-2439. PubMed ID: 28009780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virtual crossmatch by identification of donor-specific anti-human leukocyte antigen antibodies by solid-phase immunoassay: a 30-month analysis in living donor kidney transplantation.
    Morris GP; Phelan DL; Jendrisak MD; Mohanakumar T
    Hum Immunol; 2010 Mar; 71(3):268-73. PubMed ID: 20074605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epitope Analysis Aids in Transplant Decision Making by Determining the Clinical Relevance of Apparent Pre-Transplant Donor Specific Antibodies (DSA).
    Pandey S; Harville TO
    Ann Clin Lab Sci; 2019 Jan; 49(1):50-56. PubMed ID: 30814077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxic flow cytometric crossmatch in renal transplantation: a single assay to simultaneously detect antibody binding and cytotoxicity.
    Thammanichanond D; Athimang W; Paisooksantivatana K; Mongkolsuk T; Ingsathit A; Worawichawong S; Kitpoka P; Jirasiritham S; Kantachuvesiri S
    Transplant Proc; 2012 Jan; 44(1):62-5. PubMed ID: 22310580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Partially mismatched transplantation and human leukocyte antigen donor-specific antibodies.
    Gladstone DE; Zachary AA; Fuchs EJ; Luznik L; Kasamon YL; King KE; Brodsky RA; Jones RJ; Leffell MS
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):647-52. PubMed ID: 23353119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Living donor kidney transplantation in patients with donor-specific HLA antibodies enabled by anti-CD20 therapy and peritransplant apheresis.
    Klein K; Süsal C; Schäfer SM; Becker LE; Beimler J; Schwenger V; Zeier M; Schemmer P; Macher-Goeppinger S; Scherer S; Opelz G; Morath C
    Atheroscler Suppl; 2013 Jan; 14(1):199-202. PubMed ID: 23357165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Virtual crossmatch in kidney transplantation.
    Piazza A; Ozzella G; Poggi E; Caputo D; Manfreda A; Adorno D
    Transplant Proc; 2014 Sep; 46(7):2195-8. PubMed ID: 25242749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conformational Variants of the Individual HLA-I Antigens on Luminex Single Antigen Beads Used in Monitoring HLA Antibodies: Problems and Solutions.
    Jucaud V; Ravindranath MH; Terasaki PI
    Transplantation; 2017 Apr; 101(4):764-777. PubMed ID: 27495776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early acute antibody-mediated rejection of a negative flow crossmatch 3rd kidney transplant with exclusive disparity at HLA-DP.
    Mierzejewska B; Schroder PM; Baum CE; Blair A; Smith C; Duquesnoy RJ; Marrari M; Gohara A; Malhotra D; Kaw D; Liwski R; Rees MA; Stepkowski S
    Hum Immunol; 2014 Aug; 75(8):703-8. PubMed ID: 24755353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of the virtual crossmatch in solid organ transplantation.
    Amico P; Hönger G; Steiger J; Schaub S
    Curr Opin Organ Transplant; 2009 Dec; 14(6):656-61. PubMed ID: 19741534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unexpected Positive Prospective Crossmatches in Organ Transplant.
    Desoutter J; Apithy MJ; Guillaume N
    Exp Clin Transplant; 2017 Jun; 15(3):253-259. PubMed ID: 28447927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy.
    Reinsmoen NL; Lai CH; Vo A; Cao K; Ong G; Naim M; Wang Q; Jordan SC
    Transplantation; 2008 Sep; 86(6):820-5. PubMed ID: 18813107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Highly Sensitized Patients Are Well Served by Receiving a Compatible Organ Offer Based on Acceptable Mismatches.
    Heidt S; Haasnoot GW; van der Linden-van Oevelen MJH; Claas FHJ
    Front Immunol; 2021; 12():687254. PubMed ID: 34248971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of Panel Reactive Antibodies in Renal Transplant Recipients Detected by Luminex: A Single-Center Experience.
    İnal A; Özçelik Ü; Ogan Uyanık E; Külah E; Demirağ A
    Exp Clin Transplant; 2016 Aug; 14(4):401-4. PubMed ID: 26517205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum flow cytometric C1q binding antibody analysis of renal recipients with low levels of sensitization.
    Ata P; Canbakan M; Kara M; Özel L; Ünal E; Titiz Mİ
    Transplant Proc; 2012; 44(6):1652-5. PubMed ID: 22841237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
    Lawrence C; Willicombe M; Brookes PA; Santos-Nunez E; Bajaj R; Cook T; Roufosse C; Taube D; Warrens AN
    Transplantation; 2013 Jan; 95(2):341-6. PubMed ID: 23197178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.